CLINICAL_TRIALS ClinicalTrials.gov record update

The Safety Study of Stemchymal® (Allogeneic Adipose-Derived Mesenchymal Stem Cells) Treating on Acute Liver Failure - An Open-Label, Single-Center Phase I Trial

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03629015
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:55.976785+00:00
Published At: 2022-10-28T00:00:00+00:00
Record Updated At: 2022-10-28
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Stem Cells", "Adult Stem Cells", "Acute Liver Failure", "Acute-On-Chronic Liver Failure", "Steminent"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2022-10-28"
protocolSection.identificationModule.nctId: "NCT03629015"
protocolSection.identificationModule.officialTitle: "The Safety Study of Stemchymal\u00ae (Allogeneic Adipose-Derived Mesenchymal Stem Cells) Treating on Acute Liver Failure - An Open-Label, Single-Center Phase I Trial"
protocolSection.statusModule.overallStatus: "WITHDRAWN"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.